Paracetamol poisoning: beyond the nomogram

Paracetamol poisoning is the commonest overdose seen in the UK. The management of patients with paracetamol poisoning has been little changed for the past 40 years, with a weight related dose of antidote (acetylcysteine) and treatment based on nomograms relating paracetamol concentration to time fro...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:British journal of clinical pharmacology Ročník 80; číslo 1; s. 45 - 50
Hlavní autor: Bateman, D. Nicholas
Médium: Journal Article
Jazyk:angličtina
Vydáno: England John Wiley & Sons, Ltd 01.07.2015
Témata:
Acetaminophen - administration & dosage
Acetaminophen - poisoning
acetylcysteine
Acetylcysteine - administration & dosage
Acetylcysteine - therapeutic use
Analgesics, Non-Narcotic - administration & dosage
Analgesics, Non-Narcotic - poisoning
antidotes
aracetamol
biomarkers
Biomarkers - blood
Drug Overdose - drug therapy
Humans
Nomograms
poisoning
Reviews
Risk Assessment - methods
acetylcysteine
antidotes
aracetamol
poisoning
biomarkers
ISSN:0306-5251, 1365-2125, 1365-2125
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Paracetamol poisoning is the commonest overdose seen in the UK. The management of patients with paracetamol poisoning has been little changed for the past 40 years, with a weight related dose of antidote (acetylcysteine) and treatment based on nomograms relating paracetamol concentration to time from ingestion. In 2012 the UK Commission on Human Medicines recommended a revision of the nomogram, following the death of a young woman, lowering the treatment threshold for all patients. As a result many more patients were treated. This has resulted in a large increase in admissions and in the proportion suffering adverse reactions to the antidote acetylcysteine since, interestingly, higher paracetamol concentrations inhibit anaphylactoid reactions to the antidote. New approaches to assessing the toxicity of paracetamol are now emerging using new biomarkers in blood. This article discusses new approaches to risk assessment and treatment for paracetamol overdose based on recent research in this area.
AbstractList Paracetamol poisoning is the commonest overdose seen in the UK. The management of patients with paracetamol poisoning has been little changed for the past 40 years, with a weight related dose of antidote (acetylcysteine) and treatment based on nomograms relating paracetamol concentration to time from ingestion. In 2012 the UK Commission on Human Medicines recommended a revision of the nomogram, following the death of a young woman, lowering the treatment threshold for all patients. As a result many more patients were treated. This has resulted in a large increase in admissions and in the proportion suffering adverse reactions to the antidote acetylcysteine since, interestingly, higher paracetamol concentrations inhibit anaphylactoid reactions to the antidote. New approaches to assessing the toxicity of paracetamol are now emerging using new biomarkers in blood. This article discusses new approaches to risk assessment and treatment for paracetamol overdose based on recent research in this area.
Paracetamol poisoning is the commonest overdose seen in the UK. The management of patients with paracetamol poisoning has been little changed for the past 40 years, with a weight related dose of antidote (acetylcysteine) and treatment based on nomograms relating paracetamol concentration to time from ingestion. In 2012 the UK Commission on Human Medicines recommended a revision of the nomogram, following the death of a young woman, lowering the treatment threshold for all patients. As a result many more patients were treated. This has resulted in a large increase in admissions and in the proportion suffering adverse reactions to the antidote acetylcysteine since, interestingly, higher paracetamol concentrations inhibit anaphylactoid reactions to the antidote. New approaches to assessing the toxicity of paracetamol are now emerging using new biomarkers in blood. This article discusses new approaches to risk assessment and treatment for paracetamol overdose based on recent research in this area.Paracetamol poisoning is the commonest overdose seen in the UK. The management of patients with paracetamol poisoning has been little changed for the past 40 years, with a weight related dose of antidote (acetylcysteine) and treatment based on nomograms relating paracetamol concentration to time from ingestion. In 2012 the UK Commission on Human Medicines recommended a revision of the nomogram, following the death of a young woman, lowering the treatment threshold for all patients. As a result many more patients were treated. This has resulted in a large increase in admissions and in the proportion suffering adverse reactions to the antidote acetylcysteine since, interestingly, higher paracetamol concentrations inhibit anaphylactoid reactions to the antidote. New approaches to assessing the toxicity of paracetamol are now emerging using new biomarkers in blood. This article discusses new approaches to risk assessment and treatment for paracetamol overdose based on recent research in this area.
Author Bateman, D. Nicholas
Author_xml – sequence: 1
  givenname: D. Nicholas
  surname: Bateman
  fullname: Bateman, D. Nicholas
  organization: University of Edinburgh
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26099917$$D View this record in MEDLINE/PubMed
BookMark eNp9kEtLAzEUhYNU7EMX_gHpUoWpuXnNxIWgxRcUdKHrkEkzbWQmqZOp0n_v1KqooHdzF_c751xOH3V88BahfcAjaOckN4sREIHZFuoBFTwhQHgH9TDFIuGEQxf1Y3zCGCgIvoO6LSulhLSHju91rY1tdBXK4SK4GLzzs9NhblfBT4fN3A59qMKs1tUu2i50Ge3exx6gx6vLh_FNMrm7vh2fTxLDMs4SagzhLE0LkkHBWZGzLLU4BZEWjOgpxiQVVGopyFRaENq2PACVMicSZ5LRATrb-C6WeWWnxvqm1qVa1K7S9UoF7dTPi3dzNQsvinGMKaGtweGHQR2elzY2qnLR2LLU3oZlVCAkYEhxJlr04HvWV8hnQS1wtAFMHWKsbfGFAFbr8lVbvnovv2VPfrHGNbpxYf2mK_9TvLrSrv62Vhfj-43iDRrFk54
CitedBy_id crossref_primary_10_21615_cesmedicina_33_1_8
crossref_primary_10_1186_s13613_020_00762_9
crossref_primary_10_1016_j_jhep_2019_10_030
crossref_primary_10_1080_15563650_2018_1487563
crossref_primary_10_1097_01_CCN_0000578816_14164_9f
crossref_primary_10_1002_cpt_541
crossref_primary_10_1111_bcp_12789
crossref_primary_10_1111_bcp_13214
crossref_primary_10_1016_j_mpmed_2015_12_014
crossref_primary_10_1097_01_NPR_0000586020_15798_c6
crossref_primary_10_1007_s00228_019_02674_5
crossref_primary_10_1097_01_CCN_0000668560_03626_5c
crossref_primary_10_1111_bcp_15903
crossref_primary_10_1016_j_explore_2024_103102
crossref_primary_10_1136_bmjopen_2020_042765
crossref_primary_10_1177_03000605241260362
crossref_primary_10_4103_abr_abr_393_22
crossref_primary_10_1111_bcpt_13058
crossref_primary_10_1111_fcp_12184
Cites_doi 10.1542/peds.55.6.871
10.1080/15563650701864760
10.1136/bmj.317.7173.1609
10.1111/bcp.12362
10.1016/S0140-6736(74)92649-X
10.1016/S0140-6736(79)92306-7
10.1016/S0022-3565(25)29666-5
10.4049/jimmunol.1100165
10.1136/bmj.2.6198.1097
10.1136/bmj.2.5512.506
10.1016/S0140-6736(77)90612-2
10.1080/15563650802665587
10.1586/17512433.2014.880650
10.1177/096032718400300504
10.1002/cpt1974164676
10.1016/S0140-6736(76)92842-7
10.1007/BF00558131
10.1056/NEJM198812153192401
10.3109/15563650.2010.523828
10.1136/bmj.2.5512.497
10.1016/j.annemergmed.2009.05.010
10.1081/CLT-66056
10.1097/00007691-200012000-00015
10.1186/2050-6511-14-20
10.1002/hep.26294
10.3109/15563650.2012.659252
10.1016/S0140-6736(13)62062-0
10.1016/S0022-3565(25)29663-X
10.1016/S0140-6736(71)91125-1
10.1080/15563650802245497
10.1007/s00228-008-0580-9
10.1136/bmj.d2218
10.3109/15563650.2013.775292
10.1111/liv.12322
ContentType Journal Article
Copyright 2015 The British Pharmacological Society
2015 The British Pharmacological Society.
2015 The British Pharmacological Society 2015
Copyright_xml – notice: 2015 The British Pharmacological Society
– notice: 2015 The British Pharmacological Society.
– notice: 2015 The British Pharmacological Society 2015
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1111/bcp.12604
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1365-2125
EndPage 50
ExternalDocumentID PMC4500323
26099917
10_1111_bcp_12604
BCP12604
Genre reviewArticle
Journal Article
Review
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OC
23N
24P
2WC
31~
33P
36B
3O-
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
AOIJS
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FIJ
FUBAC
G-S
G.N
GODZA
GX1
H.X
HF~
HGLYW
HYE
HZI
HZ~
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
Q.N
Q11
QB0
R.K
ROL
RPM
RX1
SUPJJ
TEORI
TR2
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGXDD
AGYGG
AIDQK
AIDYY
CITATION
O8X
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c4854-3cc25477f281f54fb487e07167f42ad0027639a962d9e16aecc211399b2908943
IEDL.DBID WIN
ISICitedReferencesCount 20
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000356820500004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0306-5251
1365-2125
IngestDate Thu Aug 21 18:09:36 EDT 2025
Sun Nov 09 11:53:12 EST 2025
Thu Apr 03 07:00:50 EDT 2025
Tue Nov 18 22:21:53 EST 2025
Sat Nov 29 07:54:38 EST 2025
Wed Jan 22 17:07:24 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords acetylcysteine
antidotes
aracetamol
poisoning
biomarkers
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2015 The British Pharmacological Society.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4854-3cc25477f281f54fb487e07167f42ad0027639a962d9e16aecc211399b2908943
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://bpspubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.12604
PMID 26099917
PQID 1691017086
PQPubID 23479
PageCount 6
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4500323
proquest_miscellaneous_1691017086
pubmed_primary_26099917
crossref_primary_10_1111_bcp_12604
crossref_citationtrail_10_1111_bcp_12604
wiley_primary_10_1111_bcp_12604_BCP12604
PublicationCentury 2000
PublicationDate July 2015
PublicationDateYYYYMMDD 2015-07-01
PublicationDate_xml – month: 07
  year: 2015
  text: July 2015
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Chichester, UK
PublicationTitle British journal of clinical pharmacology
PublicationTitleAlternate Br J Clin Pharmacol
PublicationYear 2015
Publisher John Wiley & Sons, Ltd
Publisher_xml – name: John Wiley & Sons, Ltd
References 1974; 16
1966; 2
2009; 47
2013; 28
2009; 65
2012
2007; 100
2000; 22
1973; 187
1976; 2
1998; 317
1974; 1
2005; 43
1978; 36
1975; 55
2012; 50
2013; 14
2010; 48
2013; 58
2009; 54
1984; 3
2013; 51
1977; 2
2008; 46
1979; 2
2013
1989; 37
1988; 319
1971; 1
2014; 7
2014; 78
2011; 342
2011; 187
e_1_2_4_21_1
Prescott LF (e_1_2_4_15_1) 1978; 36
e_1_2_4_20_1
e_1_2_4_23_1
e_1_2_4_22_1
e_1_2_4_25_1
Mitchell JR (e_1_2_4_6_1) 1973; 187
BNF (e_1_2_4_19_1) 2012
e_1_2_4_24_1
e_1_2_4_27_1
e_1_2_4_26_1
e_1_2_4_29_1
e_1_2_4_28_1
Mitchell JR (e_1_2_4_4_1) 1973; 187
e_1_2_4_3_1
Beer C (e_1_2_4_18_1) 2007; 100
e_1_2_4_2_1
e_1_2_4_5_1
e_1_2_4_7_1
e_1_2_4_9_1
e_1_2_4_8_1
e_1_2_4_30_1
e_1_2_4_32_1
e_1_2_4_10_1
e_1_2_4_31_1
e_1_2_4_11_1
e_1_2_4_34_1
e_1_2_4_12_1
e_1_2_4_33_1
e_1_2_4_13_1
e_1_2_4_36_1
e_1_2_4_14_1
e_1_2_4_35_1
e_1_2_4_16_1
e_1_2_4_38_1
e_1_2_4_37_1
e_1_2_4_17_1
e_1_2_4_39_1
70646 - Lancet. 1977 Aug 27;2(8035):432-4
24290406 - Lancet. 2014 Feb 22;383(9918):697-704
5913083 - Br Med J. 1966 Aug 27;2(5512):497-9
2598989 - Eur J Clin Pharmacol. 1989;37(5):501-6
23473457 - Clin Toxicol (Phila). 2013 Mar;51(3):130-3
4746329 - J Pharmacol Exp Ther. 1973 Oct;187(1):211-7
4100436 - Lancet. 1971 Mar 13;1(7698):519-22
24450481 - Expert Rev Clin Pharmacol. 2014 Mar;7(2):181-9
24666324 - Br J Clin Pharmacol. 2014 Sep;78(3):610-8
21508044 - BMJ. 2011;342:d2218
17237484 - QJM. 2007 Feb;100(2):93-6
22320209 - Clin Toxicol (Phila). 2012 Feb;50(2):91-8
18958458 - Eur J Clin Pharmacol. 2009 Feb;65(2):163-8
20969501 - Clin Toxicol (Phila). 2010 Oct;48(8):787-92
1134886 - Pediatrics. 1975 Jun;55(6):871-6
59181 - Lancet. 1976 Jul 17;2(7977):109-13
24118944 - Liver Int. 2014 Mar;34(3):367-78
23556549 - BMC Pharmacol Toxicol. 2013;14:20
4746326 - J Pharmacol Exp Ther. 1973 Oct;187(1):185-94
19556028 - Ann Emerg Med. 2009 Oct;54(4):606-14
3059186 - N Engl J Med. 1988 Dec 15;319(24):1557-62
9848898 - BMJ. 1998 Dec 12;317(7173):1609-10
4417718 - Clin Pharmacol Ther. 1974 Oct;16(4):676-84
18584360 - Clin Toxicol (Phila). 2008 Jul;46(6):496-500
519312 - Br Med J. 1979 Nov 3;2(6198):1097-100
18803085 - Clin Toxicol (Phila). 2008 Sep;46(8):697-702
4132259 - Lancet. 1974 Apr 6;1(7858):588-92
16035198 - Clin Toxicol (Phila). 2005;43(4):229-34
93206 - Lancet. 1979 Dec 15;2(8155):1298
21824865 - J Immunol. 2011 Sep 15;187(6):3347-52
5913085 - Br Med J. 1966 Aug 27;2(5512):506-7
19280424 - Clin Toxicol (Phila). 2009 Feb;47(2):81-8
669953 - Health Bull (Edinb). 1978 Jul;36(4):204-12
6436169 - Hum Toxicol. 1984 Oct;3(5):393-8
11128244 - Ther Drug Monit. 2000 Dec;22(6):742-8
23390034 - Hepatology. 2013 Aug;58(2):777-87
References_xml – volume: 1
  start-page: 519
  year: 1971
  end-page: 22
  article-title: Plasma paracetamol half‐life and hepatic necrosis in patients with paracetamol overdosage
  publication-title: Lancet
– volume: 2
  start-page: 1298
  year: 1979
  article-title: Anaphylactoid reaction to N‐acetylcysteine
  publication-title: Lancet
– volume: 187
  start-page: 3347
  year: 2011
  end-page: 52
  article-title: Cyclophilin A is a damage‐associated molecular pattern molecule that mediates acetaminophen‐induced liver injury
  publication-title: J Immunol
– volume: 7
  start-page: 181
  year: 2014
  end-page: 9
  article-title: Stratification of paracetamol overdose patients using new toxicity biomarkers: current candidates and future challenges
  publication-title: Expert Rev Clin Pharmacol
– volume: 2
  start-page: 109
  year: 1976
  end-page: 13
  article-title: Cysteamine, methionine and penicillamine in the treatment of paracetamol poisoning
  publication-title: Lancet
– volume: 319
  start-page: 1557
  year: 1988
  end-page: 62
  article-title: Efficacy of oral N‐acetylcysteine in the treatment of acetaminophen overdose. Analysis of the National Multicenter Study (1976 to 1985)
  publication-title: N Engl J Med
– volume: 22
  start-page: 742
  year: 2000
  end-page: 48
  article-title: Acetaminophen causes an increased international normalized ratio by reducing functional factor VII
  publication-title: Ther Drug Monit
– volume: 187
  start-page: 211
  year: 1973
  end-page: 7
  article-title: Acetaminophen‐induced hepatic necrosis. IV. Protective role of glutathione
  publication-title: J Pharmacol Exp Ther
– year: 2013
  article-title: Keratin‐18 and microRNA‐122 complement alanine aminotransferase as novel safety biomarkers for drug‐induced liver injury in two human cohorts
  publication-title: Liver Int: Official J Int Assoc Stud Liver
– volume: 36
  start-page: 204
  year: 1978
  end-page: 12
  article-title: The chief scientist reports … prevention of hepatic necrosis following paracetamol overdosage
  publication-title: Health Bull
– volume: 2
  start-page: 1097
  year: 1979
  end-page: 100
  article-title: Intravenous N‐acetylcysteine: the treatment of choice for paracetamol poisoning
  publication-title: Br Med J
– volume: 46
  start-page: 496
  year: 2008
  end-page: 500
  article-title: Lower incidence of anaphylactoid reactions to N‐acetylcysteine in patients with high acetaminophen concentrations after overdose
  publication-title: Clin Toxicol
– volume: 16
  start-page: 676
  year: 1974
  end-page: 84
  article-title: Acetaminophen‐induced hepatic injury: protective role of glutathione in man and rationale for therapy
  publication-title: Clin Pharmacol Ther
– volume: 47
  start-page: 81
  year: 2009
  end-page: 8
  article-title: Adverse reactions associated with acetylcysteine
  publication-title: Clin Toxicol
– volume: 51
  start-page: 130
  year: 2013
  end-page: 3
  article-title: Treating acetaminophen overdose: thresholds, costs and uncertainties
  publication-title: Clin Toxicol
– volume: 187
  start-page: 185
  year: 1973
  end-page: 94
  article-title: Acetaminophen‐induced hepatic necrosis. I. Role of drug metabolism
  publication-title: J Pharmacol Exp Ther
– volume: 2
  start-page: 506
  year: 1966
  end-page: 7
  article-title: Liver damage and impaired glucose tolerance after paracetamol overdosage
  publication-title: Br Med J
– year: 2012
– volume: 3
  start-page: 393
  year: 1984
  end-page: 8
  article-title: Adverse reactions to N‐acetylcysteine
  publication-title: Hum Toxicol
– volume: 1
  start-page: 588
  year: 1974
  end-page: 92
  article-title: Successful treatment of severe paracetamol overdosage with cysteamine
  publication-title: Lancet
– volume: 37
  start-page: 501
  year: 1989
  end-page: 6
  article-title: The disposition and kinetics of intravenous N‐acetylcysteine in patients with paracetamol overdosage
  publication-title: Eur J Clin Pharmacol
– volume: 14
  start-page: 20
  year: 2013
  article-title: Scottish and Newcastle antiemetic pre‐treatment for paracetamol poisoning study (SNAP)
  publication-title: BMC Pharmacol Toxicol
– volume: 43
  start-page: 229
  year: 2005
  end-page: 34
  article-title: A new predictor of toxicity following acetaminophen overdose based on pretreatment exposure
  publication-title: Clin Toxicol
– volume: 58
  start-page: 777
  year: 2013
  end-page: 87
  article-title: Mechanistic biomarkers provide early and sensitive detection of acetaminophen‐induced acute liver injury at first presentation to hospital
  publication-title: Hepatology
– volume: 48
  start-page: 787
  year: 2010
  end-page: 92
  article-title: When do the aminotransferases rise after acute acetaminophen overdose?
  publication-title: Clin Toxicol
– volume: 50
  start-page: 91
  year: 2012
  end-page: 8
  article-title: Acetaminophen and acetylcysteine dose and duration: past, present and future
  publication-title: Clin Toxicol
– volume: 2
  start-page: 497
  year: 1966
  end-page: 9
  article-title: Acute liver necrosis following overdose of paracetamol
  publication-title: Br Med J
– volume: 55
  start-page: 871
  year: 1975
  end-page: 6
  article-title: Acetaminophen poisoning and toxicity
  publication-title: Pediatrics
– volume: 2
  start-page: 432
  year: 1977
  end-page: 4
  article-title: Treatment of paracetamol (acetaminophen) poisoning with N‐acetylcysteine
  publication-title: Lancet
– volume: 46
  start-page: 697
  year: 2008
  end-page: 702
  article-title: Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose
  publication-title: Clin Toxicol
– volume: 342
  start-page: d2218
  year: 2011
  article-title: Management of paracetamol poisoning
  publication-title: BMJ
– volume: 54
  start-page: 606
  year: 2009
  end-page: 14
  article-title: Comparison of the 20‐hour intravenous and 72‐hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning
  publication-title: Ann Emerg Med
– volume: 78
  start-page: 610
  year: 2014
  end-page: 8
  article-title: Effect of the UK's revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment
  publication-title: Br J Clin Pharmacol
– volume: 65
  start-page: 163
  year: 2009
  end-page: 8
  article-title: Renal injury at first presentation as a predictor for poor outcome in severe paracetamol poisoning referred to a liver transplant unit
  publication-title: Eur J Clin Pharmacol
– volume: 100
  start-page: 93
  year: 2007
  end-page: 6
  article-title: Liver unit admission following paracetamol overdose with concentrations below current UK treatment thresholds
  publication-title: QJM‐Mon J Assoc Phys
– volume: 28
  start-page: 2013
  year: 2013
  article-title: Reducing adverse effects from intravenous acetylcysteine treatment of paracetamol poisoning: a randomised controlled trial
  publication-title: Lancet
– volume: 317
  start-page: 1609
  year: 1998
  end-page: 10
  article-title: Paracetamol (acetaminophen) poisoning. No need to change current guidelines to accident departments
  publication-title: BMJ
– ident: e_1_2_4_16_1
  doi: 10.1542/peds.55.6.871
– ident: e_1_2_4_27_1
  doi: 10.1080/15563650701864760
– ident: e_1_2_4_17_1
  doi: 10.1136/bmj.317.7173.1609
– ident: e_1_2_4_24_1
  doi: 10.1111/bcp.12362
– ident: e_1_2_4_7_1
  doi: 10.1016/S0140-6736(74)92649-X
– ident: e_1_2_4_29_1
  doi: 10.1016/S0140-6736(79)92306-7
– volume: 187
  start-page: 211
  year: 1973
  ident: e_1_2_4_6_1
  article-title: Acetaminophen‐induced hepatic necrosis. IV. Protective role of glutathione
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(25)29666-5
– ident: e_1_2_4_38_1
  doi: 10.4049/jimmunol.1100165
– ident: e_1_2_4_10_1
  doi: 10.1136/bmj.2.6198.1097
– ident: e_1_2_4_2_1
  doi: 10.1136/bmj.2.5512.506
– ident: e_1_2_4_9_1
  doi: 10.1016/S0140-6736(77)90612-2
– ident: e_1_2_4_25_1
  doi: 10.1080/15563650802665587
– volume: 36
  start-page: 204
  year: 1978
  ident: e_1_2_4_15_1
  article-title: The chief scientist reports … prevention of hepatic necrosis following paracetamol overdosage
  publication-title: Health Bull
– ident: e_1_2_4_37_1
  doi: 10.1586/17512433.2014.880650
– ident: e_1_2_4_26_1
  doi: 10.1177/096032718400300504
– ident: e_1_2_4_5_1
  doi: 10.1002/cpt1974164676
– ident: e_1_2_4_8_1
  doi: 10.1016/S0140-6736(76)92842-7
– ident: e_1_2_4_28_1
  doi: 10.1007/BF00558131
– ident: e_1_2_4_11_1
  doi: 10.1056/NEJM198812153192401
– ident: e_1_2_4_34_1
  doi: 10.3109/15563650.2010.523828
– ident: e_1_2_4_3_1
  doi: 10.1136/bmj.2.5512.497
– ident: e_1_2_4_13_1
  doi: 10.1016/j.annemergmed.2009.05.010
– ident: e_1_2_4_35_1
  doi: 10.1081/CLT-66056
– ident: e_1_2_4_21_1
  doi: 10.1097/00007691-200012000-00015
– ident: e_1_2_4_30_1
  doi: 10.1186/2050-6511-14-20
– ident: e_1_2_4_22_1
– ident: e_1_2_4_36_1
  doi: 10.1002/hep.26294
– ident: e_1_2_4_12_1
  doi: 10.3109/15563650.2012.659252
– volume-title: British National Formulary
  year: 2012
  ident: e_1_2_4_19_1
– ident: e_1_2_4_31_1
  doi: 10.1016/S0140-6736(13)62062-0
– volume: 187
  start-page: 185
  year: 1973
  ident: e_1_2_4_4_1
  article-title: Acetaminophen‐induced hepatic necrosis. I. Role of drug metabolism
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(25)29663-X
– ident: e_1_2_4_14_1
  doi: 10.1016/S0140-6736(71)91125-1
– ident: e_1_2_4_32_1
  doi: 10.1080/15563650802245497
– ident: e_1_2_4_33_1
  doi: 10.1007/s00228-008-0580-9
– ident: e_1_2_4_20_1
  doi: 10.1136/bmj.d2218
– volume: 100
  start-page: 93
  year: 2007
  ident: e_1_2_4_18_1
  article-title: Liver unit admission following paracetamol overdose with concentrations below current UK treatment thresholds
  publication-title: QJM‐Mon J Assoc Phys
– ident: e_1_2_4_23_1
  doi: 10.3109/15563650.2013.775292
– ident: e_1_2_4_39_1
  doi: 10.1111/liv.12322
– reference: 70646 - Lancet. 1977 Aug 27;2(8035):432-4
– reference: 23390034 - Hepatology. 2013 Aug;58(2):777-87
– reference: 4417718 - Clin Pharmacol Ther. 1974 Oct;16(4):676-84
– reference: 24290406 - Lancet. 2014 Feb 22;383(9918):697-704
– reference: 1134886 - Pediatrics. 1975 Jun;55(6):871-6
– reference: 11128244 - Ther Drug Monit. 2000 Dec;22(6):742-8
– reference: 19556028 - Ann Emerg Med. 2009 Oct;54(4):606-14
– reference: 3059186 - N Engl J Med. 1988 Dec 15;319(24):1557-62
– reference: 669953 - Health Bull (Edinb). 1978 Jul;36(4):204-12
– reference: 93206 - Lancet. 1979 Dec 15;2(8155):1298
– reference: 2598989 - Eur J Clin Pharmacol. 1989;37(5):501-6
– reference: 24118944 - Liver Int. 2014 Mar;34(3):367-78
– reference: 9848898 - BMJ. 1998 Dec 12;317(7173):1609-10
– reference: 4100436 - Lancet. 1971 Mar 13;1(7698):519-22
– reference: 519312 - Br Med J. 1979 Nov 3;2(6198):1097-100
– reference: 19280424 - Clin Toxicol (Phila). 2009 Feb;47(2):81-8
– reference: 5913083 - Br Med J. 1966 Aug 27;2(5512):497-9
– reference: 18958458 - Eur J Clin Pharmacol. 2009 Feb;65(2):163-8
– reference: 59181 - Lancet. 1976 Jul 17;2(7977):109-13
– reference: 21508044 - BMJ. 2011;342:d2218
– reference: 17237484 - QJM. 2007 Feb;100(2):93-6
– reference: 4746326 - J Pharmacol Exp Ther. 1973 Oct;187(1):185-94
– reference: 24666324 - Br J Clin Pharmacol. 2014 Sep;78(3):610-8
– reference: 18584360 - Clin Toxicol (Phila). 2008 Jul;46(6):496-500
– reference: 5913085 - Br Med J. 1966 Aug 27;2(5512):506-7
– reference: 24450481 - Expert Rev Clin Pharmacol. 2014 Mar;7(2):181-9
– reference: 18803085 - Clin Toxicol (Phila). 2008 Sep;46(8):697-702
– reference: 4746329 - J Pharmacol Exp Ther. 1973 Oct;187(1):211-7
– reference: 22320209 - Clin Toxicol (Phila). 2012 Feb;50(2):91-8
– reference: 20969501 - Clin Toxicol (Phila). 2010 Oct;48(8):787-92
– reference: 6436169 - Hum Toxicol. 1984 Oct;3(5):393-8
– reference: 16035198 - Clin Toxicol (Phila). 2005;43(4):229-34
– reference: 21824865 - J Immunol. 2011 Sep 15;187(6):3347-52
– reference: 23556549 - BMC Pharmacol Toxicol. 2013;14:20
– reference: 23473457 - Clin Toxicol (Phila). 2013 Mar;51(3):130-3
– reference: 4132259 - Lancet. 1974 Apr 6;1(7858):588-92
SSID ssj0013165
Score 2.264824
SecondaryResourceType review_article
Snippet Paracetamol poisoning is the commonest overdose seen in the UK. The management of patients with paracetamol poisoning has been little changed for the past 40...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 45
SubjectTerms Acetaminophen - administration & dosage
Acetaminophen - poisoning
acetylcysteine
Acetylcysteine - administration & dosage
Acetylcysteine - therapeutic use
Analgesics, Non-Narcotic - administration & dosage
Analgesics, Non-Narcotic - poisoning
antidotes
aracetamol
biomarkers
Biomarkers - blood
Drug Overdose - drug therapy
Humans
Nomograms
poisoning
Reviews
Risk Assessment - methods
Title Paracetamol poisoning: beyond the nomogram
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbcp.12604
https://www.ncbi.nlm.nih.gov/pubmed/26099917
https://www.proquest.com/docview/1691017086
https://pubmed.ncbi.nlm.nih.gov/PMC4500323
Volume 80
WOSCitedRecordID wos000356820500004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library Full Collection 2020
  customDbUrl:
  eissn: 1365-2125
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0013165
  issn: 0306-5251
  databaseCode: DRFUL
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library Open Access
  customDbUrl:
  eissn: 1365-2125
  dateEnd: 20241207
  omitProxy: false
  ssIdentifier: ssj0013165
  issn: 0306-5251
  databaseCode: WIN
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: https://onlinelibrary.wiley.com
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3da9swED-6dg976cc-2vQjaGOEMeJS2bJlt09ttrDBCGa0LG9GkiVaaOyQpIX89z3JiZOQFgZ9M_hky3c66XfW6XcAX8VZkvsy0Z6gJvYYZcaTiZKejEyo8iiODJeu2ATv9eJ-P0k34GJ-Fqbih6h_uFnPcPO1dXAhx0tOLtXwlCIat1yglFFbveDf795iB4G6MpIWEmOwFdIZq5DN4qlbrq5FawBzPU9yGb-6Bai786qu78L2DHeSy2qg7MGGLt5DK62Iq6dtcr04hzVukxZJF5TW0w_wPbW0znoiBuU9GZY2AwmXvHMi3fkXgiCSFOXAZXp9hJvuz-vOL29WZcFTLA6ZFyiFQSLnxo-pCZmRGMJoBB4RN8wXuY1bEcWIJPLzRNNIoM0xaERcI327Z8iCT7BZlIU-AJJTwbQxCTp2wngYST-nCmewUMR-YIKoAd_m-s7UjILcVsK4z-ahCGomc5ppwJdadFjxbjwn9HlutAy9wm51iEKXD-PMUgBZZqAY37lfGbF-DLa0qJg3gK-YtxawjNurd4q7W8e8zUKcBP0Av8OZ9-WeZVed1F0c_r_oEbxDNBZWucDHsDkZPegTeKseJ3fjURPe8H7chK0ff7s3f5purD8BZmX-jQ
linkProvider Wiley-Blackwell
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1ZS8QwEB68QF-8j_WMIiKyFdOml_iioijq0ocVfStJmqCwtou7Cv57J-lu10UFwbdCJ22SySTfJJNvAHb5UZy5IlYOpzpyGGXaEbEUjgi0L7MgCnQobLKJsNGIHh_jZARO-ndhSn6IasPNWIadr42Bmw3pL1YuZPuQIhxnozDOEGiYxA0P143BGQK1iSQNKEZ3y6c9XiETx1MVHV6NvkHM75GSXxGsXYIuZ_5X-VmY7kFPclqOlTkYUfk87CUld_VHnTQHV7E6dbJHkgGr9ccCHCSG2Vl1-UvRIu3CBCHhqndMhL0CQxBHkrx4scFei3B_edE8v3J6iRYcySKfOZ6U6CeGoXYjqn2mBXoxCrFHEGrm8sy4rghkeBy4WaxowFHt6DcitBGuOTZk3hKM5UWuVoBklDOldYy2HbPQD4SbUYmTmM8j19NeUIP9foenssdCbpJhtNK-N4I9k9qeqcFOJdouqTd-Etruay1FwzCnHTxXxVsnNSxAhhwown8ul1qsPoMlDTAOaxAO6bcSMKTbw2_y5ydLvs1woHmuh-2w-v29ZunZeWIfVv8uugWTV8272_T2unGzBlMIzvwyNHgdxrqvb2oDJuR797nzummH-idNHQAy
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dT9swED-VdkK8bMCAdQww04Qm1CCcOF_TXviqQENVNIHEW2Q7tqjUJlVbJvHfc3bSlIohIfEWKefEufPZv4vPvwP4wY_jzBWxcjjVkcMo046IpXBEoH2ZBVGgQ2GLTYS9XnR3FycN-D07C1PyQ9Q_3Ixn2PnaOLgaZfqZlws5OqIIx9kStJgpItOE1vnf7u31fBeB2lKSBhZjwOXTilnIZPLUjRfXoxcg82Wu5HMMaxeh7qf3dX8VPlbgk5yUo2UNGipfh4OkZK9-7JCb-WGsSYcckGTOa_34GQ4Tw-2spnxYDMioMGlIuO79IsIegiGIJEleDG261wbcdi9uzi6dqtSCI1nkM8eTEiPFMNRuRLXPtMA4RiH6CELNXJ6Z4BWhDEclZ7GiAUfDY-SI4Ea4ZuOQeZvQzItcfQGSUc6U1jF6d8xCPxBuRiVOYz6PXE97QRt-zhSeyoqH3JTDGKSzeAQ1k1rNtOF7LToqyTf-J7Q_s1qKrmH2O3iuiodJaniADD1QhO_cKq1YPwZbGmgctiFcsG8tYGi3F-_k_XtLv818nAldD7_D2vf1nqWnZ4m9-Pp20T1YTs676fVV7882rCA688vc4G_QnI4f1A58kP-m_cl4txrrT-v-ANs
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Paracetamol+poisoning%3A+beyond+the+nomogram&rft.jtitle=British+journal+of+clinical+pharmacology&rft.au=Bateman%2C+D+Nicholas&rft.date=2015-07-01&rft.pub=John+Wiley+%26+Sons%2C+Ltd&rft.issn=0306-5251&rft.eissn=1365-2125&rft.volume=80&rft.issue=1&rft.spage=45&rft.epage=50&rft_id=info:doi/10.1111%2Fbcp.12604&rft_id=info%3Apmid%2F26099917&rft.externalDocID=PMC4500323
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0306-5251&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0306-5251&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0306-5251&client=summon